Effect of rosiglitazone on plasma adiponectin levels and arterial stiffness in subjects with prediabetes or non-diabetic metabolic syndrome
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, SG | - |
dc.contributor.author | Ryu, OH | - |
dc.contributor.author | Kim, HY | - |
dc.contributor.author | Lee, KW | - |
dc.contributor.author | Seo, JA | - |
dc.contributor.author | Kim, NH | - |
dc.contributor.author | Choi, KM | - |
dc.contributor.author | Lee, J | - |
dc.contributor.author | Baik, SH | - |
dc.contributor.author | Choi, DS | - |
dc.date.accessioned | 2021-09-09T06:37:02Z | - |
dc.date.available | 2021-09-09T06:37:02Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2006-03 | - |
dc.identifier.issn | 0804-4643 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/123155 | - |
dc.description.abstract | Objective: Thiazolidinediones have favorable influences on surrogate markers of atherosclerosis such as adiponectin. and arterial stiffness in diabetic patients. However, it is not well known whether these beneficial effects occur in Subjects without diabetes, such as prediabetes or the non-diabetic metabolic syndrome (MetS). The present study was therefore designed to evaluate the effectiveness of the insulin-sensitizing agent rosiglitazone on circulating adipocytokine levels and brachial-ankle pulse wave velocity (baPWV) in non-diabetics. Design and methods: Ninety-nine subjects with prediabetes or non-diabetic MetS were randomly assigned to either rosiglitazone or an untreated control group (50 and 49 subjects respectively). The rosiglitazone group was treated daily for 12 weeks with 4 mg rosiglitazone. All subjects received a 75 g oral glucose test (OGTT) before and after treatment. In addition. baPWV, together with the levels of adiponectin, resistin, and high sensitivity C-reactive protein (hsCRP) were determined. Results: Rosiglitazone treatment significantly increased circulating adiponectin levels (P < 0.001) relative to the control group (P = 0.21). Plasma resistin levels were unchanged in both the rosiglitazone-treated and -untreated groups. but baPWV and hsCRP were significantly decreased (P < 0.001 and P = 0.003 respectively) in the rosiglitazone group only. Multiple linear regression analysis showed that changes in plasma adiponectin and baPWV were significantly affected by rosiglitazone treatment. Conclusions: These data Suggest that rosiglitazone may have an anti-atherogenic effect in subjects with prediabetes or non-diabetic MetS. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | BIOSCIENTIFICA LTD | - |
dc.subject | PULSE-WAVE VELOCITY | - |
dc.subject | PROLIFERATOR-ACTIVATED RECEPTORS | - |
dc.subject | INTIMA-MEDIA THICKNESS | - |
dc.subject | C-REACTIVE PROTEIN | - |
dc.subject | INSULIN SENSITIVITY | - |
dc.subject | ENDOTHELIAL FUNCTION | - |
dc.subject | CARDIOVASCULAR RISK | - |
dc.subject | GENE-EXPRESSION | - |
dc.subject | ADIPOSE-TISSUE | - |
dc.subject | BLOOD-PRESSURE | - |
dc.title | Effect of rosiglitazone on plasma adiponectin levels and arterial stiffness in subjects with prediabetes or non-diabetic metabolic syndrome | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Seo, JA | - |
dc.identifier.doi | 10.1530/eje.1.02100 | - |
dc.identifier.scopusid | 2-s2.0-33645225344 | - |
dc.identifier.wosid | 000237134500011 | - |
dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF ENDOCRINOLOGY, v.154, no.3, pp.433 - 440 | - |
dc.relation.isPartOf | EUROPEAN JOURNAL OF ENDOCRINOLOGY | - |
dc.citation.title | EUROPEAN JOURNAL OF ENDOCRINOLOGY | - |
dc.citation.volume | 154 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 433 | - |
dc.citation.endPage | 440 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.subject.keywordPlus | PULSE-WAVE VELOCITY | - |
dc.subject.keywordPlus | PROLIFERATOR-ACTIVATED RECEPTORS | - |
dc.subject.keywordPlus | INTIMA-MEDIA THICKNESS | - |
dc.subject.keywordPlus | C-REACTIVE PROTEIN | - |
dc.subject.keywordPlus | INSULIN SENSITIVITY | - |
dc.subject.keywordPlus | ENDOTHELIAL FUNCTION | - |
dc.subject.keywordPlus | CARDIOVASCULAR RISK | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordPlus | ADIPOSE-TISSUE | - |
dc.subject.keywordPlus | BLOOD-PRESSURE | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.